FDA reversals on UniQure, Moderna approvals worry investors

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from…

Read More

RBA cuts interest rates to more than 2-year lows

Australia’s central bank said on Wednesday that monetary policy was restrictive with the current cash rate causing financial pain for many households, but it could not rule out further tightening if necessary to tame inflation. Pavlo Gonchar | Lightrocket | Getty Images Australia’s central bank cut its benchmark rates by 25 basis points on Tuesday,…

Read More